[go: up one dir, main page]

BR9911094A - Composições e métodos para o tratamento detosse - Google Patents

Composições e métodos para o tratamento detosse

Info

Publication number
BR9911094A
BR9911094A BR9911094-6A BR9911094A BR9911094A BR 9911094 A BR9911094 A BR 9911094A BR 9911094 A BR9911094 A BR 9911094A BR 9911094 A BR9911094 A BR 9911094A
Authority
BR
Brazil
Prior art keywords
compositions
treatment
methods
bone
detosse
Prior art date
Application number
BR9911094-6A
Other languages
English (en)
Inventor
Clive P Page
Bernard A Macleod
David M J Quastel
Original Assignee
Nortran Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nortran Pharmaceuticals Inc filed Critical Nortran Pharmaceuticals Inc
Publication of BR9911094A publication Critical patent/BR9911094A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES E MéTODOS PARA O TRATAMENTO DETOSSE". A presente invenção refere-se a composições possuindoatividade anti-tussígeno, e a um método para administrar asmesmas em animais de sangue quente, incluindo seres humanos.
BR9911094-6A 1998-06-09 1999-06-09 Composições e métodos para o tratamento detosse BR9911094A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8859798P 1998-06-09 1998-06-09
PCT/CA1999/000535 WO1999063985A1 (en) 1998-06-09 1999-06-09 Compositions and methods for treatment of cough

Publications (1)

Publication Number Publication Date
BR9911094A true BR9911094A (pt) 2001-10-30

Family

ID=22212300

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911094-6A BR9911094A (pt) 1998-06-09 1999-06-09 Composições e métodos para o tratamento detosse

Country Status (9)

Country Link
US (1) US6362197B1 (pt)
EP (1) EP1087760A1 (pt)
JP (1) JP2002517438A (pt)
KR (1) KR20010072593A (pt)
CN (1) CN1311673A (pt)
AU (1) AU762127B2 (pt)
BR (1) BR9911094A (pt)
CA (1) CA2334481A1 (pt)
WO (1) WO1999063985A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2414389A1 (en) 2000-06-23 2002-01-03 Mayo Foundation For Medical Education & Research Methods of treating neutrophil-related diseases with topical anesthetics
US7452523B2 (en) 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
US7452524B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
JP2008513445A (ja) * 2004-09-20 2008-05-01 コラス ファーマ インコーポレイテッド 吸入による送達で治療効果のある薬剤の許容性の改善方法
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20140097446A (ko) * 2006-11-20 2014-08-06 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
TW201010707A (en) * 2008-06-10 2010-03-16 Gilead Sciences Inc Corticosteroid linked beta-agonist compounds for use in therapy
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
US20120172429A1 (en) * 2009-07-10 2012-07-05 Woolf Clifford J Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
GB201304501D0 (en) 2011-09-06 2013-04-24 Verona Pharma Plc Liquid pharmaceutical compositions
WO2014037727A1 (en) * 2012-09-06 2014-03-13 Verona Pharma Plc Carcainium salts
WO2014037726A1 (en) * 2012-09-06 2014-03-13 Verona Pharma Plc Liquid pharmaceutical compositions
JP6833811B2 (ja) * 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113924094A (zh) 2019-03-11 2022-01-11 诺西恩医疗公司 酯取代的离子通道阻滞剂及其使用方法
KR20210143791A (ko) 2019-03-11 2021-11-29 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
JP7678757B2 (ja) 2019-03-11 2025-05-16 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20230022830A (ko) 2020-03-11 2023-02-16 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN111995539B (zh) * 2020-09-28 2023-08-11 郑州原理生物科技有限公司 盐酸利多卡因杂质e的制备方法
AR134196A1 (es) 2023-11-02 2025-12-10 Chiesi Farm Spa Derivados de amidas heteroarílicas como inhibidores de los canales de sodio
WO2025093590A1 (en) 2023-11-02 2025-05-08 Chiesi Farmaceutici S.P.A. Heteroaryl ester derivatives as sodium channel inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB995256A (en) * 1961-02-20 1965-06-16 Astra Apotekarnes Kem Fab Quaternary ammonium salts having anti-arrhythmic activity
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
WO1998024428A1 (en) * 1996-12-02 1998-06-11 Brigham & Women's Hospital, Inc. Long-acting local anesthetics
TW536401B (en) * 1997-09-03 2003-06-11 Cardiome Pharma Corp A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain

Also Published As

Publication number Publication date
AU4127299A (en) 1999-12-30
AU762127B2 (en) 2003-06-19
CA2334481A1 (en) 1999-12-16
EP1087760A1 (en) 2001-04-04
KR20010072593A (ko) 2001-07-31
US6362197B1 (en) 2002-03-26
JP2002517438A (ja) 2002-06-18
CN1311673A (zh) 2001-09-05
WO1999063985A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
BR9911094A (pt) Composições e métodos para o tratamento detosse
PT1041990E (pt) Composicao para o tratamento de doencas respiratorias e doencas de pele, compreendendo pelo menos um antagonista de leucotrieno e pelo menos um anti-histaminico
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
ATE374029T1 (de) Behandlung der alzheimer-krankheit durch erhöhung des cytidin-spiegels in vivo
PT784471E (pt) Metodo multifacetado para reprimir a reproducao de virus latentes em seres humanos e animais
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
BR9913441A (pt) Derivados do ácido tiazolìnico
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
BR9707252A (pt) Composições para o cuidado com tecidos incluindo poliolefinas dispersáveis e métodos para usar as mesmas
AU7814498A (en) Multivalent (in ovo) avian vaccine
GB2319725B (en) Extracting particles produced by the treating of human or animal nails
DE69831000D1 (de) Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
BR0200571A (pt) Produtos de legumes
BG105275A (en) Tan-1057 derivatives
BR0213408A (pt) Métodos de prevenção e de tratamento de infecção por flavivìrus em animais
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
MY124071A (en) Treatment of viral disease in swine
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
BR9911897B1 (pt) composição de perfume, produto desodorante, e, processo de cosmético para a redução ou prevenção do mau cheiro do corpo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1914 DE 11/09/2007.